Solventum (SOLV) vs West Pharmaceutical Services (WST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
West Pharmaceutical Services (WST) has outperformed Solventum (SOLV) over the past year, gaining 37.8% versus a gain of 19.0%. West Pharmaceutical Services is the larger company by market cap ($25.79 billion vs $14.62 billion), about 1.8 times the size. On valuation, Solventum trades at a lower forward P/E (11.9x vs 36.7x for West Pharmaceutical Services).
West Pharmaceutical Services pays a dividend yielding 0.24%, while Solventum does not currently pay one. Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 16.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SOLV | WST |
|---|---|---|
| Share price | $85.88 | $366.48 |
| Market cap | $14.62B | $25.79B |
| 1-day change | -1.33% | -1.65% |
| YTD return | +8.38% | +33.20% |
| 1-year return | +19.01% | +37.79% |
| 5-year return | — | -9.47% |
| P/E ratio (TTM) | 10.51 | 46.92 |
| Forward P/E | 11.88 | 36.72 |
| EPS (TTM) | $8.17 | $7.81 |
| Dividend yield | 0.00% | 0.24% |
| Annual dividend | $0.00 | $0.87 |
| Revenue (latest FY) | $8.32B | $3.07B |
| Revenue growth (YoY) | +0.86% | +6.25% |
| Net income (latest FY) | $1.56B | $493.70M |
| Gross margin | 53.47% | 35.91% |
| Operating margin | 26.20% | 19.03% |
| Net margin | 18.69% | 16.06% |
| 52-week high | $94.16 | $386.00 |
| 52-week low | $62.38 | $223.83 |
| Distance from 52-week high | -8.79% | -5.06% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +9.82% | +12.15% |
| Average volume | 1.02M | 629.98K |
| Shares outstanding | 170.22M | 70.38M |
| Employees | 20,584 | 10,800 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WST has outperformed SOLV by 18.8 percentage points over the past year.
- West Pharmaceutical Services trades at a higher earnings multiple (46.9x vs 10.5x trailing P/E).
- West Pharmaceutical Services grew revenue faster in its latest fiscal year (+6.25% vs +0.86%).
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
About West Pharmaceutical Services
WST stock →West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 10,800 employees
SOLV vs WST FAQ
Which is bigger, Solventum or West Pharmaceutical Services?
West Pharmaceutical Services (WST) is larger, with a market capitalization of $25.79B compared with $14.62B for Solventum (SOLV).
Which stock has performed better over the past year, SOLV or WST?
WST returned +37.79% over the past 12 months, compared with +19.01% for SOLV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, SOLV or WST?
SOLV has the lower trailing P/E at 10.5, versus 46.9 for WST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Solventum or West Pharmaceutical Services?
West Pharmaceutical Services pays a dividend yielding 0.24%, while Solventum does not currently pay a regular dividend.
Are Solventum and West Pharmaceutical Services in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.